• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

High-metastatic triple-negative breast-cancer variants selected in vivo become chemoresistant in vitro.

作者信息

Yano Shuya, Takehara Kiyoto, Kishimoto Hiroyuki, Tazawa Hiroshi, Urata Yasuo, Kagawa Shunsuke, Bouvet Michael, Fujiwara Toshiyoshi, Hoffman Robert M

机构信息

AntiCancer, Inc., San Diego, CA, USA.

Department of Surgery, University of California, San Diego, CA, USA.

出版信息

In Vitro Cell Dev Biol Anim. 2017 Apr;53(4):285-287. doi: 10.1007/s11626-016-0117-y. Epub 2017 Jan 26.

DOI:10.1007/s11626-016-0117-y
PMID:28127701
Abstract
摘要

相似文献

1
High-metastatic triple-negative breast-cancer variants selected in vivo become chemoresistant in vitro.在体内筛选出的高转移性三阴性乳腺癌变体在体外产生化疗耐药性。
In Vitro Cell Dev Biol Anim. 2017 Apr;53(4):285-287. doi: 10.1007/s11626-016-0117-y. Epub 2017 Jan 26.
2
MENA Confers Resistance to Paclitaxel in Triple-Negative Breast Cancer.MENA赋予三阴性乳腺癌对紫杉醇的耐药性。
Mol Cancer Ther. 2017 Jan;16(1):143-155. doi: 10.1158/1535-7163.MCT-16-0413. Epub 2016 Nov 3.
3
BRCA1-IRIS inactivation overcomes paclitaxel resistance in triple negative breast cancers.BRCA1-IRIS失活克服三阴性乳腺癌中的紫杉醇耐药性。
Breast Cancer Res. 2015 Jan 13;17(1):5. doi: 10.1186/s13058-014-0512-9.
4
Autophagy inhibition re-sensitizes pulse stimulation-selected paclitaxel-resistant triple negative breast cancer cells to chemotherapy-induced apoptosis.自噬抑制使脉冲刺激筛选出的耐紫杉醇三阴性乳腺癌细胞对化疗诱导的凋亡重新敏感。
Breast Cancer Res Treat. 2015 Feb;149(3):619-29. doi: 10.1007/s10549-015-3283-9. Epub 2015 Feb 1.
5
Metastasis-acquired changes in clinically actionable genes in triple negative breast cancer patients with central nervous system metastases: Focus on HER2 targeted therapies.三阴性乳腺癌中枢神经系统转移患者临床可操作基因的转移获得性改变：聚焦HER2靶向治疗
J BUON. 2017 Jul-Aug;22(4):1081.
6
TITAN: phase III study of doxorubicin/cyclophosphamide followed by ixabepilone or paclitaxel in early-stage triple-negative breast cancer.TITAN：多柔比星/环磷酰胺序贯伊沙匹隆或紫杉醇用于早期三阴性乳腺癌的III期研究。
Breast Cancer Res Treat. 2017 Aug;164(3):649-658. doi: 10.1007/s10549-017-4285-6. Epub 2017 May 15.
7
Triple negative breast cancer in BRCA1 mutation carriers with a complete radiologic response to neoadjuvant paclitaxel: a case report.携带BRCA1突变的三阴性乳腺癌患者对新辅助紫杉醇治疗有完全影像学反应：一例病例报告。
Clin Breast Cancer. 2015 Apr;15(2):e155-8. doi: 10.1016/j.clbc.2014.08.006. Epub 2014 Sep 28.
8
Safety and Efficacy of Low-dose Nanoparticle Albumin-bound Paclitaxel for HER2-negative Metastatic Breast Cancer.低剂量纳米白蛋白结合型紫杉醇治疗HER2阴性转移性乳腺癌的安全性和有效性
Anticancer Res. 2018 Jan;38(1):379-383. doi: 10.21873/anticanres.12233.
9
The Na⁺/H⁺ exchanger (NHE1) as a novel co-adjuvant target in paclitaxel therapy of triple-negative breast cancer cells.钠氢交换体（NHE1）作为三阴性乳腺癌细胞紫杉醇治疗中的新型辅助靶点。
Oncotarget. 2015 Jan 20;6(2):1262-75. doi: 10.18632/oncotarget.2860.
10
The anti-androgen drug dutasteride renders triple negative breast cancer cells more sensitive to chemotherapy via inhibition of HIF-1α-/VEGF-signaling.抗雄激素药物度他雄胺通过抑制缺氧诱导因子-1α/血管内皮生长因子信号传导，使三阴性乳腺癌细胞对化疗更敏感。
Gynecol Endocrinol. 2015 Feb;31(2):160-4. doi: 10.3109/09513590.2014.971235. Epub 2014 Oct 30.

引用本文的文献

1
Triple-Negative Breast Cancer: Basic Biology and Immuno-Oncolytic Viruses.三阴性乳腺癌：基础生物学与免疫溶瘤病毒
Cancers (Basel). 2023 Apr 21;15(8):2393. doi: 10.3390/cancers15082393.
2
IL-17-CXC Chemokine Receptor 2 Axis Facilitates Breast Cancer Progression by Up-Regulating Neutrophil Recruitment.IL-17-CXC 趋化因子受体 2 轴通过上调中性粒细胞募集促进乳腺癌进展。
Am J Pathol. 2020 Jan;190(1):222-233. doi: 10.1016/j.ajpath.2019.09.016. Epub 2019 Oct 22.
3
GFP labeling kinetics of triple-negative human breast cancer by a killer-reporter adenovirus in 3D Gelfoam® histoculture.

本文引用的文献

1
Comparison of in vitro invasiveness of high- and low-metastatic triple-negative human breast cancer visualized by color-coded imaging.通过彩色编码成像可视化的高转移性和低转移性三阴性人乳腺癌体外侵袭性比较
In Vitro Cell Dev Biol Anim. 2017 Feb;53(2):96-98. doi: 10.1007/s11626-016-0092-3. Epub 2016 Oct 24.
2
In Vivo Isolation of a Highly-aggressive Variant of Triple-negative Human Breast Cancer MDA-MB-231 Using Serial Orthotopic Transplantation.使用连续原位移植在体内分离三阴性人乳腺癌MDA-MB-231的高侵袭性变体
Anticancer Res. 2016 Aug;36(8):3817-20.
3
GSTP1 Is a Driver of Triple-Negative Breast Cancer Cell Metabolism and Pathogenicity.
在3D明胶海绵组织培养中，用一种杀伤报告腺病毒对三阴性人乳腺癌进行绿色荧光蛋白标记动力学研究。
In Vitro Cell Dev Biol Anim. 2017 Jun;53(6):479-482. doi: 10.1007/s11626-017-0133-6. Epub 2017 Feb 23.
GSTP1 是三阴性乳腺癌细胞代谢和发病机制的驱动因素。
Cell Chem Biol. 2016 May 19;23(5):567-578. doi: 10.1016/j.chembiol.2016.03.017. Epub 2016 May 12.
4
Differential post-surgical metastasis and survival in SCID, NOD-SCID and NOD-SCID-IL-2Rγ(null) mice with parental and subline variants of human breast cancer: implications for host defense mechanisms regulating metastasis.SCID、NOD-SCID 和 NOD-SCID-IL-2Rγ(null) 小鼠中具有亲本和亚系变体的人类乳腺癌的术后转移和生存的差异：对调节转移的宿主防御机制的影响。
PLoS One. 2013 Aug 14;8(8):e71270. doi: 10.1371/journal.pone.0071270. eCollection 2013.
5
PARP inhibitors stumble in breast cancer.PARP抑制剂在乳腺癌治疗中遇挫。
Nat Biotechnol. 2011 May;29(5):373-4. doi: 10.1038/nbt0511-373.
6
The bulge area is the origin of nestin-expressing pluripotent stem cells of the hair follicle.隆突区域是毛囊中巢蛋白表达的多能干细胞的起源地。
J Cell Biochem. 2011 Aug;112(8):2046-50. doi: 10.1002/jcb.23122.
7
Triple-negative breast cancer.三阴性乳腺癌。
N Engl J Med. 2010 Nov 11;363(20):1938-48. doi: 10.1056/NEJMra1001389.
8
Variations in cell form and cytoskeleton in human breast carcinoma cells in vitro.体外培养的人乳腺癌细胞的细胞形态和细胞骨架变化
Cancer Res. 1980 Sep;40(9):3118-29.